Synthecon's Grant

Synthecon raised a round of funding on January 22, 2009. Investors include National Science Foundation.

Synthecon is a company that received a SBIR Phase I grant for a project entitled: Agonist-mimetic Aptamers. Their research develops an efficient method to produce single-stranded DNAs, known as aptame…

Articles about Synthecon's Grant: